Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. (ELDN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ELDN · as of Jun 8, 2026
Key Statistics
Explore Eledon Pharmaceuticals, Inc. Data
eldn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
The ELDN analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $5.00, representing +40.45% upside from the current price of $3.56.
Competitors & Peers
eldn competitorsELDN
ABEO
ACHV
ALLO
AVIR
EDITStock Performance
Full HistoryAbout Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), …
what is eledon pharmaceuticals, inc. · eldn stock overview · eledon pharmaceuticals, inc. company profile · who is eledon pharmaceuticals, inc. ceo · eldn NASDAQ · eledon pharmaceuticals, inc. headquarters · eledon pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Eledon Pharmaceuticals, Inc. (ELDN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 17, 2014. As of the latest trading session, ELDN stock price is $3.56, with a market capitalization of $214.2M. The stock has returned +19.49% over the past 12 months and +136.61% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Eledon Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $5.00. In fiscal year 2025, Eledon Pharmaceuticals, Inc. reported revenue of — and net income of -$45.6M. For detailed data — including Eledon Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Eledon Pharmaceuticals, Inc. (ELDN) stock price is $3.56. The stock is traded on NASDAQ under the ticker symbol ELDN. The 52-week range is $1.35 – $4.60.